{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T21:43:25Z","timestamp":1776203005199,"version":"3.50.1"},"reference-count":55,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Introduction<\/jats:bold><\/jats:p><jats:p>Surgical site infections pose a significant problem in the treatment of neurosurgical procedures, regardless of the application of perioperative prophylaxis with systemic antibiotics. The infection rate in these procedures ranges from less than 1% to above 15%. Different antibiotics and administration regimes have been used in the perioperative prophylaxis so far, and there are numerous comparative studies regarding their efficiency, however, it is generally indicated that the choice thereof should be based on information and local specifics connected to the most probable bacterial causers, which would possibly contaminate the surgical site and cause infection, and moreover, the mandatory compliance with the principles of providing adequate concentration of the drug at the time of the anticipated contamination.<\/jats:p><jats:p><jats:bold>Objective<\/jats:bold><\/jats:p><jats:p>Comparing the protective effect of two perioperative prophylactic antibiotic regimes using cefuroxime (second generation cephalosporin) and ceftriaxone (third generation cephalosporin) in the prevention of postoperative surgical site infections after elective and urgent cranial and spinal neurosurgical procedures at the University Clinic for Neurosurgery in Skopje in the period of the first three months of 2016.<\/jats:p><jats:p><jats:bold>Design of the study<\/jats:bold><\/jats:p><jats:p>Prospective randomized comparative study.<\/jats:p><jats:p><jats:bold>Outcome measures<\/jats:bold><\/jats:p><jats:p>Establishing the clinical outcome represented as prevalence of superficial and deep incision and organ\/space postoperative surgical site infections.<\/jats:p><jats:p><jats:bold>Material and method<\/jats:bold><\/jats:p><jats:p>We analyzed prospectively 40 patients who received parenteral antibiotic prophylaxis with two antibiotic regimes one hour before the routine neurosurgical cranial and spinal surgical procedures; the patients were randomized in two groups, according to the order of admission and participation in the study, alternately, non-selectively, those persons who fulfilled inclusion criteria were placed in one of the two programmed regimes with cefuroxime in the first, and cefotaxime in the second compared group. All relevant demographic and perioperative patient data were analyzed for both comparative groups, especially the factors known to cause disposition (predisposition) to infections. The prevalence of postoperative infections was evaluated as the primary outcome in both comparative groups, while the secondary outcome was the postoperative infection rate after cranial and spinal neurosurgical procedures at the Neurosurgical clinic in Skopje (having in consideration that so far no data have been published in this context), as well as the prevalence of the risk factors for occurrence of postoperative infections, pre-surgically in patients undergoing neurosurgical interventions locally in the Republic of Macedonia.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold><\/jats:p><jats:p>A total of three cases of postoperative infections were registered, two of which classified as superficial incisional, while one case organ\/space infection \u2013 meningitis (elective intervention) without etiological confirmation. Both comparative groups were statistically similar, without any statistically significant differences in the basic demographic and perioperative characteristics, especially in relation to the incidence of the factors, which, regardless of the antibiotic prophylaxis, show predisposition to postoperative infections. All three cases with infections were registered in the group of persons who received prophylaxis with ceftriaxone preoperatively, with isolated etiological S. aureus agent (elective intervention) in one of them, and methicillin resistant staphylococcus aureus (MRSA) in another (urgent intervention) with superficial incisional SSI. There was no case of SSI in the group of patients who received cefuroxime before surgery.<\/jats:p><jats:p><jats:bold>Conclusion<\/jats:bold><\/jats:p><jats:p>Administration of parenteral antibiotics before surgery reduces the incidence of postoperative infections after neurosurgical procedures, especially in cases with increased risk factors for SSI, such as ACA score of \u2265 2\/3, the duration of the surgical intervention \u2265 4 hours, contaminated wound and comorbidities. Perioperative antibiotic prophylaxis should be directed to better coverage of the S.aureus arrays.<\/jats:p>","DOI":"10.1515\/prilozi-2017-0026","type":"journal-article","created":{"date-parts":[[2017,10,9]],"date-time":"2017-10-09T10:04:04Z","timestamp":1507543444000},"page":"85-97","source":"Crossref","is-referenced-by-count":3,"title":["The Importance of Perioperative Prophylaxis with Cefuroxime or Ceftriaxone in the Surgical Site Infections Prevention after Cranial and Spinal Neurosurgical Procedures"],"prefix":"10.1515","volume":"38","author":[{"given":"Aleksandra","family":"Dimovska-Gavrilovska","sequence":"first","affiliation":[{"name":"University Clinic for Neurosurgery Vodnjanska 17 1000 . Skopje"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandar","family":"Chaparoski","sequence":"additional","affiliation":[{"name":"University Clinic for Neurosurgery Vodnjanska 17 1000 . Skopje"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreja","family":"Gavrilovski","sequence":"additional","affiliation":[{"name":"University Clinic for Traumatology Vodnjanska 17 1000 . Skopje"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zvonko","family":"Milenkovikj","sequence":"additional","affiliation":[{"name":"University Clinic for Infectious Diseases Vodnjanska 17 1000 . Skopje"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2017,10,7]]},"reference":[{"key":"2021040721432683880_j_prilozi-2017-0026_ref_001_w2aab3b7c10b1b6b1ab1ab1Aa","unstructured":"1. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarwis WR: Guideline for prevention of surgical site infection, 1999. Centers for Disease Contyrol and Prevention (CDC) Hospital infection control practices advisory committee, Am J Infect Control 1999; 27:97-132"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_002_w2aab3b7c10b1b6b1ab1ab2Aa","unstructured":"2. Jiang X, Ma J, Hou F, Li J, Li R, Lang H: Neurosurgical site infection prevention: Single institute experience, Turk Neurosurg 2016; 26(2):234-239"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_003_w2aab3b7c10b1b6b1ab1ab3Aa","doi-asserted-by":"crossref","unstructured":"3. Inigo JJ, Bermejo B, Oronoz B, Herrera J, Tarifa A, Perez F, Miranda C, Lera JM: Surgical site infection in general surgery: 5-yaer analysis and assessment of the National Nosocomial Infection Surveillance (NNIS) index, Cir Esp 2006; 79:224-230","DOI":"10.1016\/S0009-739X(06)70857-0"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_004_w2aab3b7c10b1b6b1ab1ab4Aa","doi-asserted-by":"crossref","unstructured":"4. Kasatpibal N, Norgaard M, Jamulitrat SW: Improving surveillance system and surgical site infection rates through a network: A pilot study from Thailand, Clin Epidemiol 2009; 1:67-74","DOI":"10.2147\/CLEP.S5507"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_005_w2aab3b7c10b1b6b1ab1ab5Aa","doi-asserted-by":"crossref","unstructured":"5. Waits SA, Fritze D, Banerjee M, Zhang W, Kubus J, Englesbe MJ, Campbell DA Jr, Hendren S: Developing an argument for bundled interventions to reduce surgical site infection in colorectal surgery, Surgery 2014; 155:602-606","DOI":"10.1016\/j.surg.2013.12.004"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_006_w2aab3b7c10b1b6b1ab1ab6Aa","doi-asserted-by":"crossref","unstructured":"6. Ward VP, Charlett A, Fagan J, Crawshaw SC: Enhanced surgical site infection surveillance following caesarean section: Experience of a multicenter collaborative post-discharge system, J Hosp Infect 2008; 70:166-17310.1016\/j.jhin.2008.06.002","DOI":"10.1016\/j.jhin.2008.06.002"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_007_w2aab3b7c10b1b6b1ab1ab7Aa","doi-asserted-by":"crossref","unstructured":"7. Gibbons C, Bruce J, Carpenter J, Wilson AP, Wilson J, Pearson A, Lamping DL, Krukowski ZH, Reeves BC: Identification of risk factors by systematic review and development of risk-adjusted models for surgical site infection, Health Technol Assess 2011; 15:1-156","DOI":"10.3310\/hta15300"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_008_w2aab3b7c10b1b6b1ab1ab8Aa","doi-asserted-by":"crossref","unstructured":"8. Gaynes RP, Culver DH, Horan TC, Edwards JR, Richards C, Tolson JS: Surgical site infection (SSI) rates in the United States, 1992-1998: The National Nosocomial Infections Surveillance System basic SSI risk index, Clin Infect Dis 2001; 33(Suppl 2):S69-77","DOI":"10.1086\/321860"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_009_w2aab3b7c10b1b6b1ab1ab9Aa","doi-asserted-by":"crossref","unstructured":"9. Haley RW, Culver DH, White JW, Morgan WM, Emori TG, Munn VP, Hooton TM: The efficacy of infection surveillance and control programs in in preventing nosocomial infections in US hospitals, Am J Epidemiol 1985; 121:182-205","DOI":"10.1093\/oxfordjournals.aje.a113990"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_010_w2aab3b7c10b1b6b1ab1ac10Aa","doi-asserted-by":"crossref","unstructured":"10. Geubbels EL, Nagelkerke NJ, Mintjes-De Groot AJ, Vandenbroucke-Grauls CM, Grobbee DE, De Boer AS: Reduced riski of msurgical site infections through surveillance in a network, Int J Qual Health Care 2006; 18:127-133","DOI":"10.1093\/intqhc\/mzi103"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_011_w2aab3b7c10b1b6b1ab1ac11Aa","doi-asserted-by":"crossref","unstructured":"11. Healey MA, Shackford SR, Osler TM, Rogers FB, Burns E: Complications in surgical patients, Arch Surg 2002; 137:611-617","DOI":"10.1001\/archsurg.137.5.611"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_012_w2aab3b7c10b1b6b1ab1ac12Aa","unstructured":"12. Buang SS, Haspani MS: Risk factors for neurosurgical site infection after a neurosurgical procedure: A prospective observational study at Hospital Kuala Lumpur, Med J Malaysia 2012; 67(4):393-8"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_013_w2aab3b7c10b1b6b1ab1ac13Aa","doi-asserted-by":"crossref","unstructured":"13. Kulkarni AV, Drake JM, Lamberti-Pasculli M: Cerebrospinal fluid shunt infection: A prospective study of risk factors, J Neurosurg 2001; 94(2):195-20110.3171\/jns.2001.94.2.0195","DOI":"10.3171\/jns.2001.94.2.0195"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_014_w2aab3b7c10b1b6b1ab1ac14Aa","doi-asserted-by":"crossref","unstructured":"14. Valentini LG, Casali C, Chatenoud L, Chiaffarino F, Uberti-Foppa C, Broggi G: Surgical site infection after elective neurosurgery: A survey of 1747 patients, Neurosurgery 2009; 62(1):88-95","DOI":"10.1227\/01.NEU.0000311065.95496.C5"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_015_w2aab3b7c10b1b6b1ab1ac15Aa","doi-asserted-by":"crossref","unstructured":"15. Haines SJ:: Efficacy of antibiotic prophylaxis in clean neurosurgical operations, Neurosurgery 1989; 24:401-40510.1227\/00006123-198903000-00016","DOI":"10.1097\/00006123-198903000-00016"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_016_w2aab3b7c10b1b6b1ab1ac16Aa","unstructured":"16. Borges ES, Machado Ferreira SC: Relevant actions in the control of surgical site infections in neurosurgery: An integrative review, OBJN 2016; 15(4):1-9"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_017_w2aab3b7c10b1b6b1ab1ac17Aa","unstructured":"17. World Health Organization (SWZ): WHO guidelines for safe surgery, 2009, Geneva: WHO"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_018_w2aab3b7c10b1b6b1ab1ac18Aa","doi-asserted-by":"crossref","unstructured":"18. Owens CD, Stoessel K: Surgical site infections: epidemiology, microbiology and prevention, J Hosp Infect 2008; 70(S2):3-10","DOI":"10.1016\/S0195-6701(08)60017-1"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_019_w2aab3b7c10b1b6b1ab1ac19Aa","doi-asserted-by":"crossref","unstructured":"19. Edwards JR, Peterson BBA, Banerjee S, Allen-Bridson K, Morrell G, Margaret A: National Health Safety Network (NHSN) Report, data summary for 2006 through 2007, Am J Infect Control 2008; 36:609-26","DOI":"10.1016\/j.ajic.2008.08.001"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_020_w2aab3b7c10b1b6b1ab1ac20Aa","doi-asserted-by":"crossref","unstructured":"20. Schweizer ML, Cullen JJ, Perencevich EN, Vaughan Sarrazin MS: Costs associated with surgical site infections in Veterans affairs hospitals, JAMA Surg 2014; 149(6):575-81","DOI":"10.1001\/jamasurg.2013.4663"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_021_w2aab3b7c10b1b6b1ab1ac21Aa","doi-asserted-by":"crossref","unstructured":"21. Kaye KS, Schmit K, Pieper C, Sloane R, Caughlan KF, Sexton DJ, Schmader KE: The effect of increasing age on the risk factor of surgical site infection, J Infect Dis 2005; 191:1056-62","DOI":"10.1086\/428626"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_022_w2aab3b7c10b1b6b1ab1ac22Aa","doi-asserted-by":"crossref","unstructured":"22. Cruse PJ: Wound infection surveillance, Rev Infect Dis 1981; 4(3):734-4710.1093\/clinids\/3.4.734","DOI":"10.1093\/clinids\/3.4.734"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_023_w2aab3b7c10b1b6b1ab1ac23Aa","doi-asserted-by":"crossref","unstructured":"23. Vegas AA, Garcia ML: Nosocomial infection in surgery wards: A controlled study of increased duration of hospital stays and direct cost of hospitalization, Eur J Epidemiol 1993; 9(5):504-10.","DOI":"10.1007\/BF00209528"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_024_w2aab3b7c10b1b6b1ab1ac24Aa","doi-asserted-by":"crossref","unstructured":"24. Nishant, Kailash KK, Vijayraghavan PV: Prospective randomized study for antibiotic prophilaxis in spine surgery: Choice of drug, dosage and timing, Asian Spine J 2013; 7(3):196-203","DOI":"10.4184\/asj.2013.7.3.196"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_025_w2aab3b7c10b1b6b1ab1ac25Aa","doi-asserted-by":"crossref","unstructured":"25. Holloway KL, Smith KW, Wilberger J, Collins JJ: Antibiotic prophylaxis during clean neurosusrgery: A large, multicenter study using cefuroxime, Clin Ther 1996; 18(1):84-9410.1016\/S0149-2918(96)80181-0","DOI":"10.1016\/S0149-2918(96)80181-0"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_026_w2aab3b7c10b1b6b1ab1ac26Aa","unstructured":"26. Malomo AO, Adeolu AA, Odebode TO, Komolafe EO, Shokunbi MT: Prospective comparative trial of ceftriaxone versus ceftazidime as prophylactic perioperative antimicrobials in neurosurgery, ECA J Surg 2007; 12(1):89-92"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_027_w2aab3b7c10b1b6b1ab1ac27Aa","doi-asserted-by":"crossref","unstructured":"27. Zhao JZ, Wang S, Li JS, Yang J, Zang JT, He Q, Shao LL, Dai ZX, Chao XY, Lau KC: The perioperative use of ceftriaxone as infection prophylaxis in neurosurgery, Clin Neurol Neurosurg 1995; 97(4):285-9","DOI":"10.1016\/0303-8467(95)00054-N"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_028_w2aab3b7c10b1b6b1ab1ac28Aa","doi-asserted-by":"crossref","unstructured":"28. Zhu XL, Wong WK, Yeung WM, Mo P, Tsang CS, Pang KH, Po YC, Aung TH: A randomized, double-blind comparison of ampicillin\/sulbactam and ceftriaxone in the prevention of surgical-site infections after neurosurgery, Clin Ther 2001; 23(8):1281-91","DOI":"10.1016\/S0149-2918(01)80107-7"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_029_w2aab3b7c10b1b6b1ab1ac29Aa","doi-asserted-by":"crossref","unstructured":"29. Arnaboldi L: Antimicrobial prophylaxis with ceftriaxone in neurosurgical procedures, Chemother 1996; 42(5):384-390","DOI":"10.1159\/000239470"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_030_w2aab3b7c10b1b6b1ab1ac30Aa","unstructured":"30. Bodzinski J, Barczewska M, Marchel A: Ceftriaxone in short-term program of perioperational prophylaxis in neurosurgery, Neurol Neurochir Pol 1993; 27(1):55-61"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_031_w2aab3b7c10b1b6b1ab1ac31Aa","doi-asserted-by":"crossref","unstructured":"31. Barker II FG: Efficacy of prophylactic antibiotic for craniotomy: A meta-analysis, Neurosurgery 1994; 35(3):484-9210.1227\/00006123-199409000-00017","DOI":"10.1097\/00006123-199409000-00017"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_032_w2aab3b7c10b1b6b1ab1ac32Aa","doi-asserted-by":"crossref","unstructured":"32. Bullock R, van Dellen JR, Ketelbey W: A double-blind placebo-controlled trial of perioperative prophylactic antibiotics for elective neurosurgery, J Neurosurg 1988; 69(5):687-91","DOI":"10.3171\/jns.1988.69.5.0687"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_033_w2aab3b7c10b1b6b1ab1ac33Aa","doi-asserted-by":"crossref","unstructured":"33. Dempsey R, Rapp RP, Young B: Prophylactic parenteral antibiotics in clean neurosurgical procedures: A review, J Neurosurg 1988; 69:52-710.3171\/jns.1988.69.1.0052","DOI":"10.3171\/jns.1988.69.1.0052"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_034_w2aab3b7c10b1b6b1ab1ac34Aa","unstructured":"34. Djindjian M: Antibiotic prophylaxis in neurosurgery, Ann Fr Anesth Reanim 1994; 13:93-5"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_035_w2aab3b7c10b1b6b1ab1ac35Aa","unstructured":"35. Petrica A, Ionac M, Brinzeu C, Brinzeu A: Surgical site infections surveillance in neurosurgery patients, Tim Med J 2009; 3-4:1-4"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_036_w2aab3b7c10b1b6b1ab1ac36Aa","unstructured":"36. Altemeier WA: Sepsis in neurosurgery. Presidential address, Arch Surg 1982; 117(2):107-12"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_037_w2aab3b7c10b1b6b1ab1ac37Aa","doi-asserted-by":"crossref","unstructured":"37. Van Walraven C, Musselman R: The surgical site infection risk score (SSIRS): A model to predict the risk of surgical site infections, PLOS ONE 2013; 8(6):1-4","DOI":"10.1371\/journal.pone.0067167"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_038_w2aab3b7c10b1b6b1ab1ac38Aa","doi-asserted-by":"crossref","unstructured":"38. Bowater RJ, Stirling SA, Lilford RJ: Is antibiotic prophylaxis in surgery a generally effective intervention? Testing a generic hypothesis over a set of meta-analyses, Ann Surg 2009; 249:551-6","DOI":"10.1097\/SLA.0b013e318199f202"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_039_w2aab3b7c10b1b6b1ab1ac39Aa","doi-asserted-by":"crossref","unstructured":"39. Gibbons C, Bruce J, Carpenter J, Wilson AP, Wilson J: Identification of risk factors by systematic review and development of risk-adjusted models for surgical site infection, Health Technol Assess 2011; 15:1-iv","DOI":"10.3310\/hta15300"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_040_w2aab3b7c10b1b6b1ab1ac40Aa","doi-asserted-by":"crossref","unstructured":"40. Korinek AM: Risk factors for neurosurgical site infections after craniotomy: A prospective multicenter study of 2944 patients. The French study group of neurosurgical infections, the SEHP, and the C-CLIN Paris-Nord service epidemiologie hygiene et prevention. Neurosurgery 1997; 41(5):1073-81","DOI":"10.1097\/00006123-199711000-00010"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_041_w2aab3b7c10b1b6b1ab1ac41Aa","doi-asserted-by":"crossref","unstructured":"41. Margaret AO, Jennie M, Carl L: Risk factors for surgical site infection in spinal surgery, J Neurosurg (Spine 2) 2003; 98:149-55","DOI":"10.3171\/spi.2003.98.2.0149"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_042_w2aab3b7c10b1b6b1ab1ac42Aa","doi-asserted-by":"crossref","unstructured":"42. Heymsfield SB, Wadden TA: Mechanisms, pathophysiology and management of obesity, N Engl J Med 2017; 376(3):254-66","DOI":"10.1056\/NEJMra1514009"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_043_w2aab3b7c10b1b6b1ab1ac43Aa","unstructured":"43. Fry DE: Surgical site infection: Pathogenesis and prevention. CME Program. Medscape from WebMD 2003"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_044_w2aab3b7c10b1b6b1ab1ac44Aa","doi-asserted-by":"crossref","unstructured":"44. Leape LL, Brennan TA, Laird N: The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med 1991; 324 (6):377-384","DOI":"10.1056\/NEJM199102073240605"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_045_w2aab3b7c10b1b6b1ab1ac45Aa","doi-asserted-by":"crossref","unstructured":"45. Nathens AB, Cook CH, Machiedo G, Moore EE, Namias N, Nwariaku F: Defining the research agenda for surgical infection: A consensus of experts using the Delphi approach. Surg Infect 2006; 7(2):101-110","DOI":"10.1089\/sur.2006.7.101"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_046_w2aab3b7c10b1b6b1ab1ac46Aa","doi-asserted-by":"crossref","unstructured":"46. Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ: The impact of surgical-site infections in the 1990s: Attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999; 20(11):725-730","DOI":"10.1086\/501572"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_047_w2aab3b7c10b1b6b1ab1ac47Aa","unstructured":"47. Barnard B: Prevention of surgical site infections. Infect Control Today 2003; 71(4):57-60"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_048_w2aab3b7c10b1b6b1ab1ac48Aa","doi-asserted-by":"crossref","unstructured":"48. Savitz MH, Katz SS: Rationale for prophylactic antibiotics and neurosurgery. Neurosurgery 1981; 9:142-410.1227\/00006123-198108000-00005","DOI":"10.1097\/00006123-198108000-00005"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_049_w2aab3b7c10b1b6b1ab1ac49Aa","doi-asserted-by":"crossref","unstructured":"49. Stall AC, Becker E, Ludwig SC et al.: Reduction of postoperative spinal implant infection using gentamicin microspheres, Spine 2009; 34(5):479-8310.1097\/BRS.0b013e318197e96c","DOI":"10.1097\/BRS.0b013e318197e96c"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_050_w2aab3b7c10b1b6b1ab1ac50Aa","doi-asserted-by":"crossref","unstructured":"50. Hanssen AD, Osmon DR, Patel R: Local antibiotic delivery systems: Where are we and where are we going? Clin Orthop Relat Res 2005; 437:111-4","DOI":"10.1097\/01.blo.0000175122.50804.ce"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_051_w2aab3b7c10b1b6b1ab1ac51Aa","doi-asserted-by":"crossref","unstructured":"51. O\u2019Neill KR, Smith JG, Abtahi AM, Archer KR, Spengler DM, McGirt MJ, Devin CJ: Reduced surgical site infections in patients undergoing posterior spinal stabilization of traumatic injuries using vancomycin powder, Spine J 2011; 11:641-64610.1016\/j.spinee.2011.04.025","DOI":"10.1016\/j.spinee.2011.04.025"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_052_w2aab3b7c10b1b6b1ab1ac52Aa","doi-asserted-by":"crossref","unstructured":"52. McClelland III S, Hall W: Postoperative central nervous system infection: Incidence and associated factors in 2111 neurosurgical procedures, CID 2007; 45:55-9","DOI":"10.1086\/518580"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_053_w2aab3b7c10b1b6b1ab1ac53Aa","doi-asserted-by":"crossref","unstructured":"53. Borges LF: Infections in neurologic suregery: Host defenses, Neurosurg Clin N Am 1992; 3:275-8","DOI":"10.1016\/S1042-3680(18)30661-2"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_054_w2aab3b7c10b1b6b1ab1ac54Aa","doi-asserted-by":"crossref","unstructured":"54. Korinek AM, Baugnon T, Golmard JL, van Effenterre R, Coriat P, Puybasset L: Risk factors for adult nosocomial meningitis after craniotomy: Role of antibiotic prophylaxis, Neurosurgery 2006; 59:126-33","DOI":"10.1227\/01.NEU.0000220477.47323.92"},{"key":"2021040721432683880_j_prilozi-2017-0026_ref_055_w2aab3b7c10b1b6b1ab1ac55Aa","doi-asserted-by":"crossref","unstructured":"55. Mollman HD, Haines SJ: Risk factors for postoperative neurosurgical wound infection: A case-control study, J Neurosurg 1986; 64:902-610.3171\/jns.1986.64.6.0902","DOI":"10.3171\/jns.1986.64.6.0902"}],"container-title":["PRILOZI"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/content.sciendo.com\/view\/journals\/prilozi\/38\/2\/article-p85.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciendo.com\/article\/10.1515\/prilozi-2017-0026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T03:29:13Z","timestamp":1659583753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciendo.com\/article\/10.1515\/prilozi-2017-0026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,1]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,10,7]]},"published-print":{"date-parts":[[2017,9,1]]}},"alternative-id":["10.1515\/prilozi-2017-0026"],"URL":"https:\/\/doi.org\/10.1515\/prilozi-2017-0026","relation":{},"ISSN":["1857-8985","1857-9345"],"issn-type":[{"value":"1857-8985","type":"electronic"},{"value":"1857-9345","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9,1]]}}}